187 related articles for article (PubMed ID: 15305891)
1. Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study.
Andersen O; Haugaard SB; Flyvbjerg A; Andersen UB; Ørskov H; Madsbad S; Nielsen JO; Iversen J
Eur J Clin Invest; 2004 Aug; 34(8):561-8. PubMed ID: 15305891
[TBL] [Abstract][Full Text] [Related]
2. A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.
Bickel M; Zangos S; Jacobi V; Lutz T; Knecht G; Goebel F; Staszewski S; Klauke S
HIV Med; 2006 Sep; 7(6):397-403. PubMed ID: 16903985
[TBL] [Abstract][Full Text] [Related]
3. Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophy.
Bickel M; Zangos S; Lutz T; Eisen J; Knecht G; Goebel FD; Crespi CM; Jacobi V; Staszewski S; Klauke S
Scand J Infect Dis; 2008; 40(1):36-9. PubMed ID: 17852925
[TBL] [Abstract][Full Text] [Related]
4. Sustained low-dose growth hormone therapy optimizes bioactive insulin-like growth factor-I level and may enhance CD4 T-cell number in HIV infection.
Andersen O; Hansen BR; Troensegaard W; Flyvbjerg A; Madsbad S; Ørskov H; Nielsen JO; Iversen J; Haugaard SB
J Med Virol; 2010 Feb; 82(2):197-205. PubMed ID: 20029798
[TBL] [Abstract][Full Text] [Related]
5. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
Schindler K; Rieger A; Tura A; Gmeinhardt B; Touzeau-Römer V; Haider D; Pacini G; Ludvik B
Horm Metab Res; 2009 Jul; 41(7):573-9. PubMed ID: 19322744
[TBL] [Abstract][Full Text] [Related]
6. Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients.
Haugaard SB; Andersen O; Hales CN; Halsall I; Rosenfalck AM; Iversen J; Madsbad S
Eur J Clin Invest; 2006 Jun; 36(6):436-45. PubMed ID: 16684128
[TBL] [Abstract][Full Text] [Related]
7. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function.
Gillberg P; Bramnert M; Thorén M; Werner S; Johannsson G
Growth Horm IGF Res; 2001 Oct; 11(5):273-81. PubMed ID: 11735245
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome.
Feldt T; Oette M; Kroidl A; Goebels K; Fritzen R; Kambergs J; Kappert G; Vogt C; Wettstein M; Häussinger D
Infection; 2006 Apr; 34(2):55-61. PubMed ID: 16703293
[TBL] [Abstract][Full Text] [Related]
9. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
10. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
[TBL] [Abstract][Full Text] [Related]
11. Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy.
Andersen O; Haugaard SB; Hansen BR; Orskov H; Andersen UB; Madsbad S; Iversen J; Flyvbjerg A
Scand J Infect Dis; 2004; 36(11-12):832-9. PubMed ID: 15764170
[TBL] [Abstract][Full Text] [Related]
12. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.
Koutkia P; Meininger G; Canavan B; Breu J; Grinspoon S
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E296-303. PubMed ID: 14559725
[TBL] [Abstract][Full Text] [Related]
13. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
14. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
Martínez E; Domingo P; Ribera E; Milinkovic A; Arroyo JA; Conget I; Pérez-Cuevas JB; Casamitjana R; de Lazzari E; Bianchi L; Montserrat E; Roca M; Burgos R; Arnaiz JA; Gatell JM
Antivir Ther; 2003 Oct; 8(5):403-10. PubMed ID: 14640387
[TBL] [Abstract][Full Text] [Related]
16. Total energy expenditure and carbohydrate oxidation are increased in the human immunodeficiency virus lipodystrophy syndrome.
Kosmiski LA; Kuritzkes DR; Sharp TA; Hamilton JT; Lichtenstein KA; Mosca CL; Grunwald GK; Eckel RH; Hill JO
Metabolism; 2003 May; 52(5):620-5. PubMed ID: 12759894
[TBL] [Abstract][Full Text] [Related]
17. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.
Koutkia P; Canavan B; Breu J; Torriani M; Kissko J; Grinspoon S
JAMA; 2004 Jul; 292(2):210-8. PubMed ID: 15249570
[TBL] [Abstract][Full Text] [Related]
19. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.
Cavalcanti RB; Raboud J; Shen S; Kain KC; Cheung A; Walmsley S
J Infect Dis; 2007 Jun; 195(12):1754-61. PubMed ID: 17492590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
